Hopital Beaujon — Clinical Trial Site

119 Registered trials

56 Currently recruiting

Organisation

Hopital Beaujon

Location

Clichy, France

Identifier

ORG-100028421

Address

100 Boulevard Du General Leclerc, 92110, France

Departments

#2303:service d'oncologie digestive
1301:Service de Gastroentérologie et assistance nutritive
1400: Pancreatology and Digestive Oncology
2301: Service d'oncologie digestive
25001
407: Gastroenterology
92100
Anesthésie - Réanimations
Anesthésie – Réanimation
Anesthésie- Réanimation
AP-HP - Hopital Beaujon
Chirurgie hépato-pancréato-biliaire et transplantations hepatiques
Département d'Hépatologie
department of digestive oncology
Digestive oncology
Digestive oncology department
Digestivo
gastro enterology
Gastro-entérologie et hépatologie
GASTROENTEROLOGIE
Gastroentérologie Pancréatologie/ Médecine Nucléaire
Gastroentérologie, MICI et Assistance Nutritive
Gastroenterologist
Gastroenterology
Gastroenterology and hepatology
Gastroenterology, IBD, and Nutritional Assistance Service
Gynecologie-Obstetrique
Hauts-de-Seine
Hépatho-Oncologie Digestif
Hepato_Gastro_Enterology
Hépato-Gastroentérologie
hepatogastroentérologie
Hépatologie
hépatologie et gastro-enterologie
Hepatology
Hôpital Beaujon - Service d’Hépatologie – Pavillon Abrami
Intensive Care
Liver Cancer Unit and Therapeutic Innovation
Liver intensive care unit
medecine nuclear department
Medical oncologist
Medical Oncology
n/a
Neurosurgery for adults
Nuclear Medecine
Nuclear medicine
Onco-Hépatologie
ONCOLOGIE
Oncologie Digestive
Oncologie et hépatologie
Oncologie hépatique
Oncologie hépatique et Innovation Thérapeutique
Oncologie médicale
Oncologie Medicale et Digestive
oncology
pancreatology and digestive oncology
Service d'Hépatologie
Service d'Hépatologie - Pavillon Abrami
Service d'Oncologie Digestive
Service d'Oncologie Hépatique et Innovation Thérapeutique
Service d'oncologie médicale digestive
Service d’Hepatologie
Service de Gastro-Entérologie du Pr Ruszniewski
Service de gastroentérologie, MICI et assistance nutritive
Service de Médecine Interne
Service de Pancréatologie
Service de Pancréatologie et d’Oncologie Digestive
Service de Pancréatologie et Oncologie Digestive
Service de Radiologie
Service de réanimation
Service Hépatologie
Service Oncologie Médicale et Digestive
SMUR
Surgical Intensive Care Unit
Unité Cancer du foie et innovation thérapeutique
Unité du cancer du foie et de l'innovation thérapeutique

Clinical trials at this site (119)

Search interface

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensate… Recruiting

2024-512895-36-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5 2024-11-25
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting

2023-509912-27-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2024-11-07
FIRST LINE CHEMOTHERAPY FOR METASTATIC GASTRO ENTERO PANCREATIC NEUROENDOCRINE CARCINOMA Recruiting

2024-515300-39-00 METASTATIC GRADE 3 POORLY DIFFERENTIATED NEUROENDOCRINE 4 2024-10-18
Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standard of care (SoC) therapy in subjects wi… Recruiting

2023-509334-19-00 gastro-enteropancreatic neuroendocrine tumors (GEP-NETs 5 2024-10-17
PRODIGE 98- AMPIRINOX : Randomized, multicenter, Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or ge… Recruiting

2024-511070-68-01 Ampullary adenocarcinoma 5 2024-09-24
Personalized medicine for advanced biliary cancer patients Recruiting

2023-508100-38-00 Advanced Biliary Cancer (ABC) 5 2024-06-24
Locally Advanced or Metastatic Hepatocellular Carcinoma: Dose Optimization, Safety, and Efficacy of Livmoniplimab in Combination with Budiga… Recruiting

2023-504600-28-00 Metastatic Hepatocellular Carcinoma (HCC) 10 2024-05-09
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Ch… Recruiting

2023-505660-11-00 Cholangiocarcinoma (LTT, 26.0) 5 2024-04-24
A novel COMBinATorial therapy with albumin and enoxaparin in patients with decompensated cirrhosis at high-risk of poor outcome (COMBAT tria… Recruiting

2023-507073-18-00 Cirrhosis 4 2024-04-24
A randomised phase II placebo-controlled trial of ART plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) vs ART plus… Recruiting

2024-516150-22-00 HIV 4 2024-04-11
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Cirrho… Recruiting

2023-505141-48-00 Fibrosis 5 2024-03-07
Testing immunotherapy for patients with liver cancer and moderatelyaltered liver functions Recruiting

2024-516443-57-00 Patients with Hepatocellular Carcinoma (HCC) and Child- 4 2023-10-11
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma… Recruiting

2022-501943-34-00 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 5 2023-06-27
TERTIO : Evaluation de l’intérêt de combiner un vaccin inducteur de CD4-Th1 dérivé de la télomérase avec un traitement par atezolizumab et b… Recruiting

2022-500643-20-00 Patients with locally advanced, metastatic or unresecta 4 2022-09-27
EPO-TRAUMA Recruiting

2023-506081-31-00 Traumatic Injury 5 2022-03-29
Study of HM15912 in subjects with Short Bowel Syndrome-associated Intestinal Failure Recruiting

2024-515160-32-00 Short Bowel Syndrome-associated Intestinal Failure (SBS 4 2022-02-02
STUDY TO ASSESS THE SCHEMAS OF RETREATMENT WITH LUTATHERA® IN PATIENTS WITH NEW PROGRESSION OF INTESTINAL WELL-DIFFERENTIATED NEUROENDOCRINE… Recruiting

2024-511001-28-00 Neuroendocrine tumor 4 2021-12-13
The ABC-HCC Trial: A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoemboli… Recruiting

2024-512953-26-00 intermediate-stage hepatocellular carcinoma 5 2021-07-06
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cance… Recruiting

2024-515344-23-00 local advenced pancreatic adenocarcinoma 4 2021-06-17
A global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab alone in patients with hepatoce… Recruiting

2023-507689-26-00 Histologically or cytologically confirmed Locoregional 5 2019-10-07
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication: BIOMEDE 2.0 Recruiting

2023-506027-29-00 Children, adolescents and adults with newly diagnosed d 5 2014-10-01
Prospective multicenter randomized controlled double-blind label study of the prophylaxis of recurrent pouchitis after fecal microbiota tran… Ended

2024-517078-52-00 Patients operated with an IPAA for ulcerative colitis w 5 2026-01-19
A Phase 3 Trial Comparing Whether BEM/RZR is Similar to SOF/VEL in Patients with Hepatitis C Virus Infection Ended

2025-521096-31-00 Chronic Hepatitis C Virus (HCV) Infection 5 2025-10-02
A Study to Evaluate Tobevibart+Elebsiran versus Bulevirtide in Chronic HDV Infection Ended

2024-520062-54-00 Chronic Hepatitis D Virus (HDV) Infection 4 2025-07-23